PPARγ in Bacterial Infections: A Friend or Foe?

Peroxisome proliferator-activated receptor γ (PPARγ) is now recognized as an important modulator of leukocyte inflammatory responses and function. Its immunoregulatory function has been studied in a variety of contexts, including bacterial infections of the lungs and central nervous system, sepsis,...

Full description

Saved in:
Bibliographic Details
Main Authors: Aravind T. Reddy, Sowmya P. Lakshmi, Raju C. Reddy
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2016/7963540
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548048890232832
author Aravind T. Reddy
Sowmya P. Lakshmi
Raju C. Reddy
author_facet Aravind T. Reddy
Sowmya P. Lakshmi
Raju C. Reddy
author_sort Aravind T. Reddy
collection DOAJ
description Peroxisome proliferator-activated receptor γ (PPARγ) is now recognized as an important modulator of leukocyte inflammatory responses and function. Its immunoregulatory function has been studied in a variety of contexts, including bacterial infections of the lungs and central nervous system, sepsis, and conditions such as chronic granulomatous disease. Although it is generally believed that PPARγ activation is beneficial for the host during bacterial infections via its anti-inflammatory and antibacterial properties, PPARγ agonists have also been shown to dampen the host immune response and in some cases exacerbate infection by promoting leukocyte apoptosis and interfering with leukocyte migration and infiltration. In this review we discuss the role of PPARγ and its activation during bacterial infections, with focus on the potential of PPARγ agonists and perhaps antagonists as novel therapeutic modalities. We conclude that adjustment in the dosage and timing of PPARγ agonist administration, based on the competence of host antimicrobial defenses and the extent of inflammatory response and tissue injury, is critical for achieving the essential balance between pro- and anti-inflammatory effects on the immune system.
format Article
id doaj-art-4892c5c4cfd54cf8bdda7ab7f66acfb7
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-4892c5c4cfd54cf8bdda7ab7f66acfb72025-02-03T06:42:20ZengWileyPPAR Research1687-47571687-47652016-01-01201610.1155/2016/79635407963540PPARγ in Bacterial Infections: A Friend or Foe?Aravind T. Reddy0Sowmya P. Lakshmi1Raju C. Reddy2Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USAPeroxisome proliferator-activated receptor γ (PPARγ) is now recognized as an important modulator of leukocyte inflammatory responses and function. Its immunoregulatory function has been studied in a variety of contexts, including bacterial infections of the lungs and central nervous system, sepsis, and conditions such as chronic granulomatous disease. Although it is generally believed that PPARγ activation is beneficial for the host during bacterial infections via its anti-inflammatory and antibacterial properties, PPARγ agonists have also been shown to dampen the host immune response and in some cases exacerbate infection by promoting leukocyte apoptosis and interfering with leukocyte migration and infiltration. In this review we discuss the role of PPARγ and its activation during bacterial infections, with focus on the potential of PPARγ agonists and perhaps antagonists as novel therapeutic modalities. We conclude that adjustment in the dosage and timing of PPARγ agonist administration, based on the competence of host antimicrobial defenses and the extent of inflammatory response and tissue injury, is critical for achieving the essential balance between pro- and anti-inflammatory effects on the immune system.http://dx.doi.org/10.1155/2016/7963540
spellingShingle Aravind T. Reddy
Sowmya P. Lakshmi
Raju C. Reddy
PPARγ in Bacterial Infections: A Friend or Foe?
PPAR Research
title PPARγ in Bacterial Infections: A Friend or Foe?
title_full PPARγ in Bacterial Infections: A Friend or Foe?
title_fullStr PPARγ in Bacterial Infections: A Friend or Foe?
title_full_unstemmed PPARγ in Bacterial Infections: A Friend or Foe?
title_short PPARγ in Bacterial Infections: A Friend or Foe?
title_sort pparγ in bacterial infections a friend or foe
url http://dx.doi.org/10.1155/2016/7963540
work_keys_str_mv AT aravindtreddy pparginbacterialinfectionsafriendorfoe
AT sowmyaplakshmi pparginbacterialinfectionsafriendorfoe
AT rajucreddy pparginbacterialinfectionsafriendorfoe